Whole-brain atrophy as a measure of prog
✍
Susie M.D. Henley; Edward J. Wild; Nicola Z. Hobbs; Chris Frost; David G. MacMan
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
English
⚖ 305 KB
👁 1 views
## Abstract Therapeutic trials in Huntington's disease (HD) are challenging as clinical progression is slow and variable and reliable biomarkers are lacking. We used magnetic resonance imaging and the brain boundary shift integral to quantify whole‐brain atrophy rates over 1 year in early and prema